Literature DB >> 35135987

Alignment Between Resident Medical Condition Regard Scale Scores and Desire to Treat Patients With Opioid Use Disorder.

Jocelyn Wu1, Rory Aufderheide, Travis Campbell, Orrin Myers, David Stromberg, Yuko M Komesu.   

Abstract

OBJECTIVES: To (1) evaluate attitudes of resident physicians towards patients with opioid use disorder (OUD) and (2) identify characteristics associated with residents' desire to treat patients with OUD.
METHODS: We administered the validated medical condition regard scale (MCRS), a question regarding desire to treat patients with OUD, and a demographic questionnaire to residents in multiple specialties at the University of New Mexico (family medicine, psychiatry, emergency medicine, internal medicine, anesthesiology, general surgery, obstetrics/gynecology).
RESULTS: One hundred sixty-three of 307 residents (53%) responded to the survey; 146 provided complete responses to the "desire" and MCRS questions. Response rates, MCRS, and desire to care for patients with OUD varied between specialties ( P < 0.001); family medicine had highest MCRS and desire to care scores; surgery, anesthesiology had low scores. MCRS and resident "desire" scores were highly correlated on univariate analysis ( r = 0.73, P < 0.001); resident demographics were not. On logistic regression, resident desire to care for OUD increased with MCRS scores ( P < 0.001). The predicated probability of desire to care for OUD was ≥80% with MCRS >57; MCRS classification skill on receiver operator curve analysis was excellent (area under curve = 0.81 [95% confidence interval 0.74, 0.88], and specialty-adjusted MCRS area under curve = 0.85 [95% confidence interval 0.79, 0.91]).
CONCLUSIONS: High resident regard for patients with OUD on MCRS was directly related to resident's desire to provide OUD care. MCRS may offer a tool to alter or individualize OUD education, potentially influencing the OUD workforce of the future.
Copyright © 2022 American Society of Addiction Medicine.

Entities:  

Mesh:

Year:  2022        PMID: 35135987      PMCID: PMC9357850          DOI: 10.1097/ADM.0000000000000933

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  7 in total

1.  Health student regard for substance-using patients as measured by the Medical Condition Regard Scale: a systematic review.

Authors:  K Ducray; M Pilch
Journal:  Ir J Psychol Med       Date:  2017-09

2.  Changes in psychiatry residents' attitudes towards individuals with substance use disorders over the course of residency training.

Authors:  Jonathan Avery; Bernadine H Han; Erin Zerbo; Guojiao Wu; Elizabeth Mauer; Joseph Avery; Stephen Ross; Julie B Penzner
Journal:  Am J Addict       Date:  2016-10-17

3.  Improved Emergency Medicine Physician Attitudes Towards Individuals with Opioid Use Disorder Following Naloxone Kit Training.

Authors:  Giselle Appel; Joseph J Avery; Kaylee Ho; Zhanna Livshits; Rama B Rao; Jonathan Avery
Journal:  Am J Emerg Med       Date:  2019-11-19       Impact factor: 2.469

4.  Stigmatization of substance use disorders among internal medicine residents.

Authors:  Ellen C Meltzer; Alexandra Suppes; Sam Burns; Andrew Shuman; Alex Orfanos; Christopher V Sturiano; Pamela Charney; Joseph J Fins
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

5.  An Exploration of Emergency Physicians' Attitudes Toward Patients With Substance Use Disorder.

Authors:  Cecelia Kathleen Mendiola; Giorgio Galetto; Michael Fingerhood
Journal:  J Addict Med       Date:  2018 Mar/Apr       Impact factor: 3.702

6.  The medical condition regard scale: measuring reactions to diagnoses.

Authors:  George W Christison; Mark G Haviland; Matt L Riggs
Journal:  Acad Med       Date:  2002-03       Impact factor: 6.893

7.  Improvement in Residents' Attitudes Toward Individuals with Substance Use Disorders Following an Online Training Module on Stigma.

Authors:  Jonathan Avery; Daniel Knoepflmacher; Elizabeth Mauer; Kristopher A Kast; Miranda Greiner; Joseph Avery; Julie B Penzner
Journal:  HSS J       Date:  2018-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.